Oxaliplatin EP Impurity B
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

89955-85-1Oxaliplatin EP Impurity B

● In Stock

Catalogue No.:VE0025071
CAS No.:89955-85-1
Mol. Formula:C6H18N2O2Pt
Mol. Weight:345.30 g/mol

Additional information on CAS 89955-85-1

Parent drug

Oxaliplatin

IUPAC Name

(SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diamine-κ2N,N′]platinum (diaquodiaminocyclohexaneplatinum; supplied as dinitrate)

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

C1CC[C@H]([C@@H](C1)[NH-])[NH-].O.O.[Pt+4]

InChI

InChI=1S/C6H12N2.2H2O.Pt/c7-5-3-1-2-4-6(5)8;;;/h5-8H, 1-4H2;2*1H2;/q-2;;;+4/t5-, 6-;;;/m1…/s1

Description

Oxaliplatin EP Impurity B (CAS 89955-85-1) is a defined degradation product monitored in oxaliplatin batches to support impurity profiling and specification compliance. Characterized by LC-MS and confirmed by 1H NMR | this impurity exhibits distinct chromatographic behavior and mass fragmentation patterns that facilitate unambiguous identification. Quantifiable by validated HPLC methods with established retention time and response factors | its detection helps elucidate degradation pathways | assess purification efficiency and define acceptance criteria. Reporting and control of Oxaliplatin EP Impurity B align with pharmacopoeial impurity identification and quantification practices to maintain batch consistency and regulatory traceability.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url